GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals Plc (NAS:BDRX) » Definitions » Accumulated other comprehensive income (loss)

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Accumulated other comprehensive income (loss) : $67.09 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Biodexa Pharmaceuticals Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Biodexa Pharmaceuticals's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $67.09 Mil.

Biodexa Pharmaceuticals's quarterly Accumulated other comprehensive income (loss) increased from Dec. 2022 ($64.56 Mil) to Jun. 2023 ($66.92 Mil) and increased from Jun. 2023 ($66.92 Mil) to Dec. 2023 ($67.09 Mil).

Biodexa Pharmaceuticals's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($70.48 Mil) to Dec. 2022 ($64.56 Mil) but then increased from Dec. 2022 ($64.56 Mil) to Dec. 2023 ($67.09 Mil).

Biodexa Pharmaceuticals Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Biodexa Pharmaceuticals's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biodexa Pharmaceuticals Accumulated other comprehensive income (loss) Chart

Biodexa Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 71.24 70.48 64.56 67.09

Biodexa Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.48 - 64.56 66.92 67.09

Biodexa Pharmaceuticals Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Biodexa Pharmaceuticals Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Biodexa Pharmaceuticals's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Biodexa Pharmaceuticals (Biodexa Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biodexa Pharmaceuticals Plc (NAS:BDRX) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
HSTC THAR RVLPQ ATNF SNPX SLRX ENSC PHIO NBSE PXMD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5MP:Germany
Address
1 Caspian Point, Caspian Way, Cardiff, GBR, CF10 4DQ
Website
https://www.biodexapharma.com
Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.